EUVIMEDEUVIMED entdecken
Crossref

FGFR2 fusions assessed by NGS, FISH, and immunohistochemistry in intrahepatic cholangiocarcinoma

Zi Cao, Yichen Yang, Shasha Liu, Lin Sun, Yanxue Liu, Ye Luo, Jian Wang, Yan Sun iD

Journal of Gastroenterology · 2025-02 · 60 (2) · 235-246

DOI: 10.1007/s00535-024-02175-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology, online erschienen am 13.11.2024. Verfasst von Zi Cao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical R…. Hauptthemen laut MEDLINE: Receptor, Fibroblast Growth Factor, Type 2, Cholangiocarcinoma, Bile Duct Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China, the Key Project in 14th Five-Year Plan Special for Cancer Prevention and Treatment Research from Tianjin Cancer Institute, the Construction Project of Cancer Precision Diagnosis and Drug Treatment Technology from TUCIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Fibroblast Growth Factor, Type 2CholangiocarcinomaBile Duct NeoplasmsHumansImmunohistochemistryFemaleHigh-Throughput Nucleotide SequencingIn Situ Hybridization, FluorescenceMaleMiddle AgedAgedAdult

Stichwörter der Autor:innen

FGFR2 fusionsIntrahepatic cholangiocarcinomaPathological diagnosis

Substanzen

Receptor, Fibroblast Growth Factor, Type 2FGFR2 protein, human

Autor:innen und Institutionen

  • Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Key Laboratory of Digestive Cancer,…
  • Department of Pancreatic Carcinoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Key Laboratory of Digest…

ORCID-Profile: Yan Sun

Förderung

  • National Natural Science Foundation of China
  • the Key Project in 14th Five-Year Plan Special for Cancer Prevention and Treatment Research from Tianjin Cancer Institute
  • the Construction Project of Cancer Precision Diagnosis and Drug Treatment Technology from TUCIH
  • Tianjin Key Medical Discipline (Pathology) Construction Project

Zitieren

APA

Cao, Z., Yang, Y., Liu, S., Sun, L., Liu, Y., Luo, Y., Wang, J., & Sun, Y. (2025). FGFR2 fusions assessed by NGS, FISH, and immunohistochemistry in intrahepatic cholangiocarcinoma. Journal of Gastroenterology, 60(2), 235-246. https://doi.org/10.1007/s00535-024-02175-y

Vancouver

Cao Z, Yang Y, Liu S, Sun L, Liu Y, Luo Y, et al. FGFR2 fusions assessed by NGS, FISH, and immunohistochemistry in intrahepatic cholangiocarcinoma. Journal of Gastroenterology. 2025;60(2):235-246. doi:10.1007/s00535-024-02175-y

BibTeX
@article{Cao2025,
  author = {Cao, Zi and Yang, Yichen and Liu, Shasha and Sun, Lin and Liu, Yanxue and Luo, Ye and Wang, Jian and Sun, Yan},
  title = {FGFR2 fusions assessed by NGS, FISH, and immunohistochemistry in intrahepatic cholangiocarcinoma},
  journal = {Journal of Gastroenterology},
  year = {2025},
  volume = {60},
  number = {2},
  pages = {235--246},
  doi = {10.1007/s00535-024-02175-y}
}
Kostenlos starten →